Erasca, Inc.
ERAS- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001761918
No open-market purchases or sales by Erasca, Inc. insiders were filed in the last 90 days; 256 institutions reported holding it in 13F filings for Q2 2026, worth $5.13B in total; no superinvestor holds it.
Superinvestors holding ERAS, Q2 2026
No superinvestor reported holding ERAS in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of ERAS each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q1 2022
0 superinvestors holding at quarter end
- Sold out
- HHLR Advisors (Hillhouse)
Q3 2021
1 superinvestor holding at quarter end